Treatment franchises akin to Alan Wake and Management “ought to have bought extra”, the corporate’s new CEO has mentioned.
Jean-Charles Gaudechon was appointed as Treatment’s new boss again in March, prompting raised eyebrows from followers of the studio’s offbeat single-player fare. Gaudechon’s resume consists of practically 5 years at EA, with a selected concentrate on the PC and cell variations of FIFA. Since then, he is labored on varied sport-related ventures, together with two years working a fantasy NFL platform.
In a brand new interview with The Sport Enterprise, Gaudechon acknowledged a few of the skepticism surrounding his previous whereas stating that he knew Treatment’s “one-of-a-kind” creativity wanted to be “protected.” On the similar time, Gaudechon mentioned he believed the corporate “may make some enhancements” to make sure its work discovered a wider viewers.
“Treatment is likely one of the few studios which is genuinely supported by gamers,” Gaudechon mentioned. “Even my announcement was one thing I cherished, as a result of folks had been defending Treatment. After I was introduced, folks from the trade and shut buddies despatched me messages saying issues like: ‘JC, that is superior. Congrats.’ And the final line was, ‘Do not f*** it up.’ It was: ‘We love Treatment a lot. Do not f*** it up.’ That exhibits you the way a lot folks love Treatment.”
Treatment has launched a flurry of video games over the previous 5 years, although none have been breakout hits. Its multiplayer experiment FBC: Firebreak was a flop, whereas sluggish gross sales of Alan Wake 2 meant the sport took over a yr to show a revenue. Its work on the marketing campaign for Korean shooter CrossfireX reviewed poorly, whereas its long-in-development Max Payne and Max Payne 2 remakes had been introduced 4 years in the past with nothing seen since.
Within the short-term, the studio is specializing in Management Resonant, the sequel to 2019’s well-received Management that is at present due sooner or later this yr. However Gaudechon mentioned he was conscious that Treatment’s franchises want an even bigger viewers — one thing its strategic partnership with Annapurna for TV and movie variations introduced again in 2024 will hopefully present.
“Management, Alan Wake, and so on. may give much more,” Gaudechon mentioned. “There is a imaginative and prescient on pondering greater for a few of these IPs, which want to search out its viewers a lot, a lot additional than the present viewers. It’s tremendous thrilling.
“We have to assume extra about how we’re approaching our IPs as a franchise,” he continued. “How can we develop the neighborhood? [Our deal with] Annapurna goes into making our video games, our franchises shine additional and attain an viewers that does not exist right this moment.
“It is a pity, I feel Alan Wake ought to have bought extra. Management ought to have bought extra. To me, that is one of many first issues we have to repair, even earlier than attempting to make extra video games to a sure extent. To start with, maximize the potential of those now we have, as a result of they’re unimaginable. And cross-media goes to assist us try this.”
IGN lately took a better have a look at Management Resonant, and got here away impressed by its aggressive, fast-paced fight. As of but, there isn’t any phrase on when this yr it’s going to launch.
Tom Phillips is IGN’s Information Editor. You may attain Tom at [email protected] or discover him on Bluesky @tomphillipseg.bsky.social
Source link
